Advances in De Novo Drug Design: From Conventional to Machine Learning Methods

De novo drug design is a computational approach that generates novel molecular structures from atomic building blocks with no a priori relationships. Conventional methods include structure-based and ligand-based design, which depend on the properties of the active site of a biological target or its...

Descripción completa

Detalles Bibliográficos
Autores principales: Mouchlis, Varnavas D., Afantitis, Antreas, Serra, Angela, Fratello, Michele, Papadiamantis, Anastasios G., Aidinis, Vassilis, Lynch, Iseult, Greco, Dario, Melagraki, Georgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915729/
https://www.ncbi.nlm.nih.gov/pubmed/33562347
http://dx.doi.org/10.3390/ijms22041676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915729/
https://www.ncbi.nlm.nih.gov/pubmed/33562347
http://dx.doi.org/10.3390/ijms22041676

Ejemplares similares